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Biofilms in Medicine
Marshall Gelbman

BIOFILMS: AN INTRODUCTORY OVERVIEW
In 1862 Louis Pasteur introduced the “Germ Theory of Disease.” Subsequently the study
of microbiology has flourished greatly and its medical significance has continuously grown.
Many microbial organisms implicated in disease have been identified and studies. A general
science of medical bacteriology has been determined and is widely taught. Such study has been
largely based upon the activity of individual free-swimming (planktonic) cells and colonies that
they form. However, microorganisms often form communities called biofilms which can have
properties that very different from their planktonic predecessors.
Biofilms are mucoid aggregates of microorganisms which tend to grow on surfaces
exposed to water. Biofilms are not the only form of microbial cell aggregate but are
distinguished from other aggregates by specific properties. Another form of microbial aggregate
is the familiar bacterial colony. Colonies tend to feed on their undersurface and utilize the
gaseous surface above for gas exchange; they are usually clones of a single preceding cell
(Wimpenny 2000). Biofilms are characterized by their locations at phase boundaries (ibid.) and
their production of Extracellular Polymeric Substance or EPS. The sliminess of biofilms is due to
their enveloping EPS matrix. The phase boundary at which biofilms generally form is Solid:
Liquid (there are a few examples of biofilms growing at other phase boundaries but they tend to
have industrial or environmental applications). An additional characteristic of biofilms which is
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not generally cited in their description is the strong alteration of their cell physiology from that of
planktonic cells (Donlan and Costerton 2002).
Biofilms grow on many surfaces, in many environments, and with many different effects.
The most common example of a biofilm is dental plaque; however biofilms also grow on many
other natural and artificial surfaces within the body for which they have been implicated in many
diseases. Biofilms are also prevalent on household surfaces such as cutting boards, counters,
toilets, sinks, tubs, and the interior of pipes.
Although biofilms appear to serve only adverse functions, they have many positive users
in the environment and industry. For example, biofilms are used in water treatment filters to
metabolize organic substances that are within the water. This strategy has been shown to
decrease microbial proliferation downstream (Cunningham 2007). Biofilms are also used in
“Bioremediation” activities in which they are utilized to metabolize toxic materials that
contaminate soil or water into safe (possibly beneficial) byproducts (ibid).
Biofilms tend to have different medical implications than do planktonic cells and thus
require different treatments. Treating biofilm infections requires an understanding of biofilms.
To truly understand the effects of biofilms we must take a deeper look at their structure and
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THE SCIENCE OF BIOFILMS
It is initially important to note that although we may investigate a variety of controlled
laboratory-grown biofilms of defined compositions, the biofilms found in natural environments
have highly heterogeneous compositions comprised of numerous bacterial species as well as
fungal organisms. The composition of a biofilm changes dynamically as some organisms and
organic material are incorporated from the surroundings and some are emitted to the
surroundings (Wimpenny 2000). The composition is regulated by a complex variety of genetic
and environmental factors.
FORMATION AND GROWTH
Ironically, biofilms have been shown to form more easily in high shear environments
(where high mechanical pressure, such as the flow of fluid, is applied to the biofilm).
Additionally, the biofilms that form in high shear environments are much stronger than those in
low shear environments. Research also shows that biofilms form as easily on smooth surfaces as
they do on rough surfaces (Donlan and Costerton 2002).
Busscher and van der Mei depict biofilm proliferation in eight semi-sequential steps
(Busscher and van der Mei 2000).
1) Deposition of a conditioning film on the substratum surface
2) Mass transport of microorganisms to the substratum
3) Initial adhesion of microorganisms to the substratum
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4) Co-adhesion to attached microbes
5) Anchoring by appendages and polymers to the substratum
6) Co-aggregation of planktonic microbes
7) Growth of the biofilm
8) Detachment of biofilm material.
Each of these steps is an independent phenomenon worthy of great research and description.
Colonization by microorganisms is always preceded by the development of a
conditioning film of macromolecules that absorb to the substratum surface. Conditioning films
form due to the diffusive and ubiquitous properties of macromolecules. The composition of a
conditioning film is related to the chemical properties of the substratum surface and the
macromolecules within its surroundings. Examples can include salivary matter on dental
surfaces, tears on contact lenses, and urinary components on a catheter surface (Ibid).
There are a variety of methods by which microorganisms reach a substratum; these
include passive forms of transport such as Brownian motion, convective transport (movement by
fluid), and sedimentation (due to difference in the specific gravity of the microbes and the mass
fluid surrounding them), as well as active (flagellar) transport. Current research indicates that
chemotaxis mediated active transport is not a factor, yet there is only limited research on such a
premise (Davies 2000).
The initial adhesion of microorganisms is by van-der Waals forces while there is even
some repulsion due to the corresponding negative electrostatic charges of the substratum and
microbial surfaces. Cellular motility appears to be the force that counteracts such repulsion
(Davies 2000). Other early factors can be acid base interaction as well as hydrophobic
interaction. The degree of relative hydrophobicity between the cell, the substratum and
surrounding liquid has been shown to influence initial attachment (Ibid.). This initial adhesion is
quite reversible, however it becomes stronger as water is removed from between the interacting
surfaces.
Microbial adhesion becomes irreversible when the cells are anchored by EPS polymers
and/or cellular appendages such as pili. These macromolecular structures adhere by dipole, ionic,
hydrogen bond, and hydrophobic interactions. Research indicates that phenomena such as the
secretion of EPS and the protrusion/extension of cellular appendages are activated in response to
surface association (Davies 2000).
Adhesion throughout a biofilm is apparently a common theme in the science of biofilms.
Two predominant styles of cell-to-cell adhesion are seen in the development of a biofilm;
Coadhesion and Coaggregation. Coadhesion refers to the binding of a planktonic cell to a biofilm
cell. Coaggregates are planktonic aggregates of microbial cells which can be incorporated as
units into biofilms by binding the substratum or by Coadhesion (Kolenbrander et al. 2000).
Following the “early events” of biofilm formation, the biofilm proliferates primarily by
cellular growth of the biofilm cells. Research has shown that substrata-attached Pseudomonas
reproduce at an extremely slow rate, with a generation time inversely relates to the attachment
strength, indicating that growth is not an early event (Busscher and van der Mei 2000).
An essential step in the biofilms development cycle is detachment. Biofilms are subject to
numerous physical and chemical forces many which can disrupt cell-to-cell interactions causing
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detachment by part of the biofilm. If the interaction between the substratum and biofilm cells is
broken, complete detachment occurs (Ibid.).
Microbes throughout nature display defense mechanisms towards their competition. Early
colonizers of biofilms have been shown to prevent further colonization by other species through
the secretion of specific bio surfactants which alter the chemical or physical properties of the
surface in ways which prevent attachment of the undesired species (Ibid.).
STRUCTURE OF BIOFILMS
Prior to the use of Confocal Lens Scanning Microscopy (CLSM) in biofilm study, there
were many misconceptions of biofilm structure. Biofilms were thought to be homogeneous
unstructured accumulations of bacteria on surfaces. CLSM provided accurate images of
unprepared live biofilms which contradicted these early beliefs. Prior study had been with
electron microscopy which requires dehydration of samples (Donlan and Costerton 2002).
Dispute had raged over the correct biofilm structure with three common models
observed. Some believed biofilms to be irregular branched or simple stalked structures, others
believed biofilms to be fairly flat and homogeneous structures while others argued that biofilms
are composed of mushroom or tulip shaped structures which are internally accessed by pores.
Subsequent study has indicated that all three models are correct and depend on the available
nutrient resources. The first model had been found in water distribution systems, which are low
nutrient environment. The second model appears where nutrient concentration is very high e.g.
the human body. The third model is observed in laboratory growth in which media containing
moderate nutrition is utilized. Both presence of specific substrates and concentration of those
present relate to a biofilm’s structure (Wimpenny 2000).
As previously described, biofilms in nature are composed of multiple species and mutants
with structural and physiological properties that can be harnessed for the entire “community”.
Under certain growth conditions P. aeruginosa biofilms have been shown to form mushroom
shaped structures. Research has shown that the stalks of the mushroom are formed of a specific
population and the mushroom caps are formed by a motile subpopulation which travels up the
stalk to reside atop it (Parsek and Fuqua 2004).
Biofilms are composed of approximately 15% cells and 85% matrix. The structural units
of a biofilm are microcolonies; these structures feature many of the biofilm implied properties
such as quorum sensing, antimicrobial resistance, and detachment. Water channels flow between
microcolonies of sessile cells. Microcolonies of biofilms in environments with high shear forces
have been shown to assume tadpole shapes which oscillate in the bulk fluid. Interestingly,
detachment of microcolonies can have dire medical results as they can travel in the planktonic
manner while retaining such properties as antimicrobial resistance (Donlan and Costerton 2002).
Considering that the matrix content of biofilms dwarfs that of cells, understanding the
EPS which forms the matrix is of great importance.
The abbreviation of EPS has remained a staple term in biofilm study, however it has
multiple long forms associated with it. They include extracellular polysaccharides,
exopolysaccharides, exopolymeric substances, exopolymers, and extracellular polymeric
substances (Flemming et al. 2000).
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Although confusion in determining the correct long form of the term “EPS” may be quite
trivial, there is practical confusion in determining the composition of EPS. This is primarily due
to the dynamic properties of this substance. The composition of EPS differs based on which
organisms are present, and by their surrounding environment (Parsek and Fuqua 2004).
While polysaccharides such as alginate were believed to be the primary components of
EPS, many studies have shown proteins and nucleic acids to prevail in quantity. In addition to
polysaccharide, protein and nucleic acid components, EPS also contains lipids and phospholipids
as well as humic substances (Flemming et al. 2000).
EPS is formed primarily of polymers bearing charged functional groups such as
phosphate, carboxylate, and sulfate groups. Alginate which has been found in large
concentrations within P. aeruginosa biofilms is formed of mannuronate and guluronate
monomers; the carboxyl groups of these moieties are anionic. Other anions prevalent in EPS are
proteins and nucleic acids. The charged functional groups of these polymers relate to biofilm
structure (Flemming et al. 2000).
UNRAVELING THE “BIOFILM PHENOTYPE”
As described above, the behavior of cells embedded within a biofilm, differs greatly from
that of planktonic cells. Julian Wimpenny states in regard to the behavior of biofilms as
communities that “the sum of its activities is greater than the sum of all the activities of is
constituent members,” and that “…a community might have emergent properties” (Wimpenny
2000). Theses distinctions are both genetic and environmental in source.
In terms of generic expression, there is a definite deviation in the physiology of the
bacterial cells of a biofilm. In regard to the environmental influence of phenotype, there are
apparent differences in the collective action of the varied multitude of microbial cells that form a
biofilm and their planktonic analogues.
Environmental differences can be attributed to the presence of the surrounding EPS
matrix and to the heterogeneity of the biofilm population. The variety of species and mutants
within a biofilm can be though to act together as a single multicellular unit which utilizes
different cell types for the differing functions for which they are optimally suited. However, the
genetic basis for the biofilm phenotype is a much more complex matter requiring a more
complex explanation.
Molecular explanation of the biofilm phenotype is related to two cell density-dependent
mechanisms; quorum sensing and gene transfer.
As its name implies. Quorum Sensing (QS) is a microbial cell to cell (pheromone)
signaling system which is dependent upon cell concentration. Signal molecules are secreted by
some cells; if the cell density is low they diffuse providing a minimal effect. If the cell density is
high, a sufficient (threshold) quantity of signal molecules is present to activate the receptors of
other cells in the vicinity inducing a signal transduction cascade which activates the expression
of a number of genes (Stoodley et al. 2000).
Quorum sensing signals induce a multitude of properties including the development of
genetic competence (the ability to genetically transform), synthesis of antibiotics, and even
virulence (Cvitkovitch et al. 2003).
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Such quorum sensing activities occur frequently when there is a high concentration of
cells. Biofilms always indicate a high concentration of cells and are thus probable locations for
quorum sensing to occur. Additionally, quorum sensing pathways have been shown to induce
biofilm, development (Stoodley et al. 2000).
Quorum sensing is also implicated in bacterial dispersions from biofilms. Such dispersion
occurs by expression of density- dependent genes which code for enzymes that degrade EPS
matrix thus freeing cells from it (Davies 2000).
There are various specific quorum sensing pathways utilized. Gram negative bacteria
such as P. aeruginosa primarily on Acyl-Homoserine Lactones (AHLs) as inducers. Gram
positive species, such as the various streptococci, have their own variety of inducers molecules.
For example, many streptococci utilize molecules classified as Competence Stimulating Peptides
(CSPs) which act by QS to activate cascades leading to genetic regulation of numerous
properties which are likely to include those which influence the “biofilm phenotype”
(Cvitkovitch et al. 2003).
During horizontal gene transfer (transformation and conjugation), fragments of genetic
material are transferred among microbial populations conferring a variety of phenotypic
properties to non-descending cells.
Cells must be in a state of genetic competence to accept DNA by gene transfer.
Competence stimulating peptides are so-names due to their induction of competence in their
recipient cells. This implies that high cell density, as is found within biofilms, greatly increases
the level of transformation. Gene transfer is also increased within biofilms due to the presence of
an “abundant extracellular gene pool” (Cvitkovitch et al. 2003).
Conjugation rates also appear to be higher for surface associated cells than for cells
within liquid culture (Ehlers 2000).
It is apparent that the increased level of gene transfer within biofilms provides a source of
phenotype distinction from planktonic microbes. As noted other factors are quorum sensing, and
environmental distinctions such as the protective Eps matrix and the communal interaction of
differing species and mutants.
BIOFILM INFECTIONS
Above, numerous physiological and structural features of laboratory studied biofilms are
described. It is now appropriate to discuss the biofilms that grow within the human body.
Biofilms have been found to grow extensively on a number of medical and anatomical surfaces
within the human body. In fact the NH indicates that more than 60% of microbial infections are
of the biofilm type (Hentzer and Givskov 2003).
Is it important to note the many specific biofilms observed within the body, as well as to
truly understand their implications and their distinctions from planktonic flora.
BIOFILMS AND CHRONIC INFECTIONS
As previously mentioned biofilms are phenotypically distinct from suspended microbes;
yet the primary methods microbial research have been studies of planktonic cell cultures. This is
unfortunate as a multitude of human infections are biofilm based.
Previous bacterial epidemics were planktonic cells that could be easily eliminated with
antibiotics and by increasing immune function by vaccination. These infections acted in the acute
37

manner. However, with such conditions quite controlled, a newer breed of infections has
appeared. These infections are not as invasive yet persist for prolonged periods of time with
sporadic flare-ups. These diseases also appeared to be caused by common organisms for which
the victims were perceived to possess immunity. When the organisms were cultured and tested
for antibiotic susceptibility they were deemed sensitive to the conventional drugs; yet patient
treatment with the antibiotics failed. These chronic infections, resistant to traditional
antimicrobial elements were determined to be of the biofilm, type. Biofilms are noted to be the
most defensive prokaryotic “life strategy” (Costerton et al. 2003).
Progressing in the field of medical microbiology requires acknowledgment of the distinct
biofilm phenotype, research methods altered for biofilm study, and realization that biofilms
induce chronic infections requiring altered treatment mechanisms (Ibid).
SURVEY OF HUMAN BIOFILM INFECTIONS
Below are some examples of common biofilm growth on the natural surfaces of the
human body, as well as biofilms which colonize implanted medical devices.
1) Dental Biofilms and Implications
The most common example of biofilms in the body, and possible the most studied, is that
of dental plaque.
The initial event in plaque formation is the development of an acquired pellicle on the
enamel surface of teeth. An acquired pellicle is a protein rich conditioning film
derived from saliva. Pellicle formation is followed by colonization by normal oral
flora. In the days following colonization, a biofilm matrix begins to appear. These
events directly follow cleaning of the enamel surface (Donlan and Costerton 2002).
If proliferation of the biofilm is undistributed for a period of 2-3 weeks, a biofilm with a
depth of 50-100µm is observed. This biofilm is termed plaque. If the plaque becomes
mineralized by calcium and phosphate ions it becomes calculus or tartar. Eventually
plaque colonizes the lateral surfaces of teeth as well as the gingival sulcus (between
the tooth and gingival surface); such plaque masses induce periodontal disease and
dental caries (erosion of the teeth) (Ibid.).
2) Native Valve Endocarditis
Vascular injuries commonly induce a form of endocarditis termed Nonbacterial
Thrombotic Endocarditis (NTBE).
A potentially fatal biofilm infection of the body that is linked to bacterial Native
Valve Endocarditis (NVE). NVE is caused by adhesion of microorganisms of the
endothelial surfaces of the cardiac valves which are damaged by NTBE.
In regions of NTBE a high level of fibronectins are secreted by the cells, platelets,
and fibroblasts present. Several bacteria feature receptors and bind the fibronectins;
formation of microcolonies follows (Ibid.).
Research shows that these bacteria/fibronectin unions develop so that the bacteria
are encapsulated within fibronectins which protects them from phagocytosis. Fibronectins
also bind leukocytes and can thus hinder their motility (Ibid.).
Biofilms on heart valves can directly damage the underlying tissues. These
biofilms can also disseminate fragments by detachment which can form emboli. Fungal
38

biofilms are found to be the predominant culprit of theses emboli as their biofilms can be
thick (Ibid.).
3) Biofilms and Otitis Media
Otitis Media (OM) is a bacterial induced inflammation of the middle ear tissues.
Common among children is Chronic Otitis Media with Effusion (COME). COME is a
chronic condition in which a viscous fluid is found within the middle ear. Biofilms have
been found on the mucosal surface of the middle ear of COME patients (Costerton et al.
2003).
One mechanism utilized to treat COME is the insertion of tympanostomy tubes into the
ear to alleviate pressure buildup. Unfortunately many of these tubes have been
demonstrated to provide a new surface for biofilm colonization. However, silicone
tympanostomy tubes bombarded with ions have been shown to remain uncontaminated
(Donlan and Costerton 2002).
4) Biofilms and Cystic Fibrosis
Cystic fibrosis (CF) is a recessive genetic disorder found predominately among
Caucasians of European decent. CF is primarily characterized by respiratory infections as
well as other abnormalities throughout the body.
During infancy and early childhood, the lungs of CF patients are infected by
organisms such as Staphylococcus aureus and Haemophilus influenzae which can cause
tissue damage. Such damage to the epithelia increases the adhesion of Pseudomonas
aeruginosa cells. P. aeruginosa subsequently become the primary colonizers and induce
chronic infection. Chronic P. aeruginosa infection is the predominant cause of
respiratory dysfunction and subsequent death in CF patients (Lyczak et al. 2002).
An important factor in the P. aeruginosa infections of the CF patient’s airway is it
growth as a biofilm. Electron microscopy has demonstrated the presence of P. aeruginosa
biofilms in CF lungs. As explained above, growth in the resistant biofilm phenotype is
implicated as a cause of chronic disease. Additionally, research has related the quorum
sensing regulation of P. aeruginosa virulence to that of biofilm growth (Lyczak et al.
2002).
5) Biofilms and Central Venous Catheters
Central Venous Catheters (CVCs) are utilized to administer substances into large
veins of the neck chest or groin. Many pathogenic micro-flora colonize the lumen and
external surfaces of CVCs. Biofilms of multiple species have been found growing on
CVC surfaces (Murga et al. 2001).
An early event in biofilm growth on CVC surfaces is the development of a
conditioning film of blood on the catheter surface. Although catheters are flushed after
blood is drawn through them, it is assumed many serum proteins remain on the surface.
The blood proteins fibronectin (described above in regard to NVE pathogenesis) and
fibrinogen have been shown to affect surface attachment of microbes, inducing
attachment of many organisms (Murga et al. 2001).
6) Biofilm Growth on Urethral Catheters
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Urinary tract infections are extremely common among patients with long-term
urinary catheters installed. Clinical evidence shows that is it quite complicated to
eliminate such infections while the catheter is present (Stickler et al. 1998).
Permanent urinary catheters can go unchanged for as long as 3 months allowing
infected urine to circulate within them. Biofilms have been shown to grow on the interior
of such catheters, often to densities which impede urinary out-flow (Stickler et al. 1998).
Biofilms within urinary catheters have been observed in-vivo and in-vitro by
scanning and transmission electron microscopy (Donlan and Costerton 2002).
ANTIBIOTIC RESISTANCE OF BIOFILMS
Numerous clinical scenarios and research studies have been demonstrated the inherent
resistance of biofilms to conventional antimicrobial agents. Generally biofilms cannot be
eradicated by the same antibiotic regiments that can eliminate their planktonic constituents
(Costerton et al. 2003).
It is accepted that the resistance of biofilm enveloped microbes to antimicrobial agents
cannot be related to a single factor but is the result of multiple factors which are tied to the
biofilm phenotype (Parsek and Fuqua 2004).
RESTRICTION PENETRATION
The initial factor considered for antimicrobial resistance in biofilms is the penetration
restriction of their matrix. Restricted penetration is caused by two major mechanisms; the action
of the matrix as a diffusion barrier, and the binding of matrix polymers to antimicrobial particles.
Consideration of the restricted penetration model has demonstrated its ability to hinder
influx of large molecules such as lysozymes; however it does not eliminate the entry of small
antimicrobial molecules. Penetration restriction has been shown to merely slow the penetration
of such drugs. Such retarted diffusion can however protect biofilms from degradable
antimicrobials as it presents the opportunity for degradation factors such as beta-lactamases to
act.
the
synergistic
cooperation
of
diffusion
restriction
and
antimicrobial
destruction/modification is a highly effective resistance mechanism (Lewis 2001).
ALTERED GROWTH RATE
Another factor commonly cited in the discussion of antimicrobial resistance of biofilms is
the relationship between growth rate and the killing effect of antimicrobials. Biofilm cells have
substantially decreased growth rates; many antimicrobials require cells to be growing for any
efficacy. Most other antibiotics (e.g. advanced beta-lactams such as cephalosporins and
fluorouqinolones) feature decreased efficacy with decreased growth rates (Lewis 2001).
ALTERED PHENOTYPE
A predominant factor cited in the discussion of biofilm resistance to antimicrobials is the
“biofilm phenotype”. It is believed that biofilms feature physiology that is distinct from that of
planktonic cells. As described above such distinction are the results of quorum sensing, increased
gene transfer and possible surface association. These factors affect the expressed genotype of
cells. An altered phenotype can result in alterations to antimicrobial absorption and efficacy
(Parsek and Fuqua 2004).
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PERSISTER CELLS
Kim Lewis describes the presence of subpopulation of “persister cells” within the biofilm
which are not easily eradicated. It is believed that even with the aforementioned mechanisms of
antimicrobial resistance most of the biofilm cells can be eliminated with certain antibiotics;
however these persister cells are not eliminated.
Such subpopulations of persisters are found within planktonic populations but are
believed to be eliminated by the immune system after antibiotics eliminate the vast majority of
the cells. Lewis hypothesized that the biofilm matrix protects the persister cells from immunity
factors thus maintaining persistence (Lewis 2001).
The hypothesis that biofilms protect persists from immunity factors may require review.
Parsek and Fuqua quote Jeff Leid to have reported at the Biofilms 2003 meeting that human
leukocytes do penetrate biofilms (Parsek and Fuqua 2004). It is likely that persisters are
responsible for increasing the resistance of biofilms by a different mechanism.
TREATMENT AND PREVENTION OF BIOFILM INFECTIONS
Numerous biofilms relevant in medicine have been discussed as well as their highly
resistant nature. It is now essential to propose strategies for preventing, eradication, and treating,
biofilm infections. There is not a single target for such strategies but a multitude of targets which
must be considered.
PREVENTION OF BIOFILM GROWTH
Prior to exploration of strategies for the treatment of existing biofilms, it is wise to
consider some methods by which biofilm growth can be initially prevented.
The general steps in biofilm formulation described above indicate mechanisms by which
biofilm formation can be inhibited.
Initially, primary colonizers must adhere to the substratum surface. If adherence to the
substratum can be decreased, biofilm growth can also be decreased. One approach to prevent
biofilm growth on medical devices is to alter the surface properties of the biomaterials. This
hypothesis is supported by J. Chandra and associates who demonstrated that chemical
modification of biomaterials influenced the ability of C. albicans to form biofilms on them
(Chandra et al. 2005).
In addition to material alterations, adjustment of clinical procedures and standards can
also decrease biofilm formation on medical devices. For this to occur it is important that the
medical community recognizes the existence of biofilms as well as their dire implications.
Modifications should be made in the scheduling and methods by which medical devices are
installed and replaced (Costerton et al. 2003).
There are also occasions when it is appropriate to utilize prophylactic antibiotic therapy
to eliminate planktonic populations to prevent colonization of anatomical and medical device
surfaces. Acknowledging the patterns of human biofilm infections can help to identify such
occasions.
ELIMINATING BIOFILMS
While there is no central solution, many mechanisms have been proposed to eliminate
biofilms. Most of the proposed methods will require much more intensive research prior to any
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clinical relevance. However, many biofilm infections can be eliminated utilizing current
antimicrobial agents by unique regimens which are depicted simple laboratory susceptibility
tests. A prevalent theme is the administration of various antibiotic combinations. Saginur and
associates as well as Slinger and associates found that specific combinations of antimicrobials
are effective in treating biofilms. These same antibiotics are ineffective against biofilms when
administered independently (Saginur et al. 2005, Slinger et al. 2006).
Assuming that persister cells are the predominant basis of biofilm resistance, Kim Lewis
presents a possible treatment regimen. Lewis suggests administering a bactericidal antibiotic,
withdrawing from treatment, and then re-administrating to the agent.
The first administration is to eliminate the majority of cells; the normal cells. The
withdrawal period is to allow growth of the remaining (persister) cells. During this time the vast
majority if the population will lose their persister phenotype leaving a relatively insignificant
population of persisters. These “normal” cells will now be eliminated by the second drug
administration. This mechanism is proposed primarily for cases of direct antibiotic application;
where drug delivery is controlled. For example: administration of antibiotics via aerosol directly
to the Cystic Fibrosis airway (Lewis 2001).
Many new antibiotic targets have been proposed for the treatment of biofilms. One such
methods in the inhibition of quorum sensing. Theoretically, quorum sensing can be inhibited in
three ways: inhibition of signal generation, inhibition of signal dissemination, and inhibition of
signal reception (Hentzer and Giskov 2003).
Interestingly, efficacy of antibiotics against biofilms has been shown to increase in the
presence of ultra sound or low-strength electric fields (Donlan and Costerton 2002). These
phenomena are not yet clinically significant.
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